Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
Home > News > Komen News

  


Bookmark and Share

Organizers Anticipate More Participants for Second Susan G. Komen Israel Race for the Cure®

Race May 3 Builds on Successful 2010 Event for Breast Cancer Awareness, Programs and Research


HERZLIA, Israel – January 18, 2012 – With more than 4,000 women and men expected to be diagnosed with breast cancer in Israel this year, women and families will take to the streets for the second time to raise funds and awareness of breast cancer in the 2012 Susan G. Komen Israel Race for the Cure®, scheduled in Jerusalem May 3.

Komen is working in partnership with the Naamat organization and the Jerusalem Municipality for the 3km event, one of more than 140 Komen races worldwide which raise awareness and funds for breast cancer programs. In 2010, more than 5,000 people participated in the first Israel Race for the Cure, and organizers hope to increase that number in 2012.

“The first Race in 2010 was an event we will never forget,” said Margo K. Lucero, vice president of business development and partnerships with Susan G. Komen for the Cure. “We witnessed people of all nationalities and religions, marching together in friendship and unity against the common scourge of this disease.”

The 2012 Race details were announced today at an event hosted by Ms. Julie Fisher, chairperson of the Race and wife of U.S. Ambassador Dan Shapiro. “It is very meaningful to see people of all religions and nationalities working together toward a common goal of ending suffering from a terrible disease,”  Fisher said. “Breast cancer doesn’t respect borders, politics or religion, and that is why this Race, and the work it helps to fund, is open to all “


Since 1982, Susan G. Komen for the Cure has granted nearly $2 billion to global research and health programs,  including $3 million to organizations in Israel including the Weizmann Institute of Science, Hebrew University-Hadassah Hospital in Jerusalem and NGO's such as Naamat, Beit Natan, The Galilee Society, NISPED, the Israel Cancer Association and others


In Israel, breast cancer accounts for nearly 30 percent of all new cancer cases, with 1,000 women and men expected to die of the disease this year. Lucero said a focus of this year’s Israel Race for the Cure will be additional outreach to Arab, Ethiopian and Russian women, and ultra-orthodox women living in Israel, all of whom can face economic or cultural barriers to early detection and cancer care.  “We want all women in Israel to know that they are welcome to walk with us,” she said.

Komen was founded by Nancy Goodman Brinker, who promised her dying sister, Susan Goodman Komen, that she would do everything she could to end breast cancer. Susan Komen died of breast cancer in 1980 and the organization that bears her name was founded two years later.

Since then, Komen has worked through partnerships in more than 50 countries to provide research and advocacy programs, funded largely through its signature Race for the Cure series.  More than 1.7 million people participate worldwide in the 140 Komen races held annually, allowing Komen to provide more than $40 million US to international research and health programs.

Komen’s international research and outreach programs have helped reduce breast cancer death rates in the U.S. and western countries, while providing new treatments and new understanding of the disease.

“We have made significant progress against this disease in 30 years, but clearly have far more to do to create a world where breast cancer is conquered,” Lucero said.

Those interested in joining the race can visit komen.org/israel.


Some stats and numbers:

• Somewhere in the world, a woman dies of breast cancer every 74 seconds.
• Worldwide, 1.6 million women will be diagnosed with breast cancer this year.
• Breast cancer is the most common form of women’s cancers in Israel, with 4,000 women and men diagnosed annually accounting for nearly 30 percent of all new cancer cases in the country.